The presence of plasmid-mediated resistance genes among uropathogenes isolated from diabetic and non-diabetic patients with chronic pyelonephritis

Authors

  • O.I. Chub Kharkov medical academy of poslediplomnogo education
  • O.V. Bilchenko Kharkov medical academy of poslediplomnogo education

DOI:

https://doi.org/10.22141/2307-1257.0.4.10.2014.76048

Keywords:

chronic pyelonephritis, diabetes mellitus, antibiotic resistance plasmids, extended spectrum β-lactamases

Abstract

Increased multidrug resistance of extended-spectrum beta-lactamases (ESBLs) compromises the efficacy of treatment of urinary tract infections. The objective of this study is to determine the prevalence of ESBL-producing uropathogens from patients with chronic pyelonephritis (CP) and to evaluate the risk factors of these types of infections. Screening for the presence of plasmid-mediated ESBL was performed by polymerase chain reaction. Out of 105 patients, 22 (20.9%) revealed strains with resistance genes: 11 (36.7%), 11 (36.7%) and 8 (26.7%) were identified to carry bla(TEM), bla(SHV) and bla(CTX-M) beta-lactamase genes, respectively. We have demonstrated that prevalence of the resistance among patients with CP combined with type 2 DM was 31.3%, while among patients with CP without type 2 DM was 27.4%; however the difference between these groups was not significant. The main factors related with appearance of plasmid-mediated resistance genes were age range above 55 years, Chronic Kidney Disease stage ІІІ and ІV, in-patient treatment history, history of using antibiotics last year. Isolation and detection of ESBL-producing strains are essential fоr the sеlection оf the mоst effеctive antibiоtic for the empiric trеatment.

Downloads

Download data is not yet available.

References

Колесник М.О. Адаптована клінічна настанова з кращої практики діагностики, лікування та профілактики інфекцій сечової системи у жінок / М.О. Колесник, Н.М. Степанова, Л.О. Лебідь [та ін.] // Український журнал нефрології та діалізу. — 2012. — № 2(34). — С. 53-77.

Колесник М.О. Медико-профілактична допомога хворим нефрологічного профілю в Україні / М.О. Колесник, Н.О. Сайдакова, Н.І. Козлюк, С.С. Ніколаєнко // Український журнал нефрології та діалізу. — 2013. — № 3(39). — С. 3-14.

Колесник Н.А. Почки и диабет: от понимания проблемы к своевременной и адекватной терапии / Н.А. Колесник // Здоров’я України. — 2009. — № 13–14. — С. 13-15.

Переверзев А.С. Особенности инфекций мочевых путей у пациентов с сахарным диабетом / А.С. Переверзев // Здоров’я України. — 2008. — № 8. — С. 10-11.

Колесник М.О. Класифікація хвороб сечової системи для нефрологічної практики / М.О. Колесник, І. Дудар, Н. Степанова [та ін.] // Український журнал нефрології та діалізу. — 2013. — № 4(40). — С. 3-7.

Grabe M. Guidelineson Urological Infections // European Association of Urology. — 2013.

European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). — Stockholm: ECDC, 2013.

Gibold L. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital / L. Gibold // Clin. Microbiol. Infect. — 2014. — № 20(1). — Р. 20-26.

Rawat D. Extended-spectrum β-lactamasesin Gram Negative Bacteria / D. Rawat // J. Glob. Infect. Dis. — 2010. — № 2(3). — Р. 263-274.

Dalhoff А. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use / А. Dalhoff // Interdisciplinary Perspectives on Infectious Diseases. — 2012. — ID 976273. — Р. 1-37.

Arnfinn Sundsfjord. Genetic methods for detection of antimicrobial resistance / Arnfinn Sundsfjord // Dahlapmis. — 2004. — № 12. — Р. 815-837.

Sader H.S. SENTRY Antimicrobial Surveillance Program, 2009–2012 / H.S. Sader, Farrell D.J., Flamm R.K. [et al.] // Int. J. Antimicrob. Agents. — 2014. — № 43(4). — Р. 328-334.

Kang C.I. Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum β-Lactamase Producing Escherichia coli Strains / C.I. Kang, Y.M. Wi, M.Y. Lee [et al.] // J. Clin. Microbiol. — 2012. — № 50(2). — Р. 312-317.

Huijbers P.M. Extended-spectrum and AmpC β-lactamase-producing Escherichia coli in broilers and people living and/or working on broiler farms: prevalence, risk factors and molecular characteristics / Huijbers P.M., Graat E.A., Haenen A.P. [et al.] // J. Antimicrob. Chemother. — 2014. — № 69(10). — Р. 2669-2675.

Valenza G. Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community / Valenza G., Nickel S., Pfeifer Y. [et al.] // Antimicrob. Agents Chemother. — 2014. — № 58(2). — Р. 1228-1230.

Published

2022-02-14

How to Cite

Chub, O., & Bilchenko, O. (2022). The presence of plasmid-mediated resistance genes among uropathogenes isolated from diabetic and non-diabetic patients with chronic pyelonephritis. KIDNEYS, (4.10), 17–19. https://doi.org/10.22141/2307-1257.0.4.10.2014.76048

Issue

Section

Original Articles